| Literature DB >> 34527781 |
Deepthi Darwin1, Renita Lorina Castelino1, Gogineni Subhas Babu1, Mohamed Faizal Asan1, Anand Shankar Sarkar1, Soundarya Shaktivel1.
Abstract
Oral cancer, a part of head-and-neck cancer (HNC), is associated with a high risk of cancer-associated weight loss causing cachexia which is still an understudied illness. Cachexia is a host-phagocytic syndrome caused by the multiple factors, resulting in the severity of heterogenic fashion. For the current review, a bibliographic search was done in PubMed and other databases for the English articles published from the year 1980 to 2021. Recent studies have revealed that cachexia associated with 35%-60% of all the oral cancer patients is either due to the implication of the tumor or obstruction of food intake for which a strong need for nutritional assistance and hydration is desired. The health of cancer individuals undergoing chemotherapy or bone marrow transplant is negatively affected by poor oral health and reduced dentition status. The impact of a deficient oral condition is not clearly understood to date, possibly due to the limited number of studies and a lack of widely accepted clinical trials to prevent cachexia. The masticatory function of such patients is drastically affected thus contributing to the decreased nutritional status causing wasting of tissues. The aim of this article is to provide substantial evidence that poor oral hygiene with an altered dentition status negatively influences the energy balance of oral cancer patients who experience wasting. Copyright:Entities:
Keywords: Cachexia; dentition; mastication; oral hygiene; tooth loss
Year: 2021 PMID: 34527781 PMCID: PMC8420925 DOI: 10.4103/apjon.apjon-2139
Source DB: PubMed Journal: Asia Pac J Oncol Nurs ISSN: 2347-5625
Summary of the oral signs in cancer cachexia caused by oral hygiene
| Oral signs | Cause |
|---|---|
| Pain | Due to after-effects of cancer treatment with its severity impacted by the treatment |
| Oral mucositis | Seen due to decreased salivary secretion and atrophy of the oral mucosa |
| Viral infections | These are most commonly caused by the viruses that belong to the herpes family |
| Bacterial infections | Any prior tooth infection or chronic periodontal conditions leads to a local bacterial infection |
| Fungal infections | Burning sensation, dysgeusia, and a variety of other clinical presentations are seen in the oral cavity which is most commonly caused by |
| Periodontal disease | A chronic bacterial infection causes periodontal diseases. Nevertheless, it is also heavily influenced by a number of other risk factors in the cachexia associated with oral cancer patients |
| Alveolar bone and tooth loss | Alveolar bone loss is caused by persistent infections of the periodontium. Long-standing carious lesions may be related with loss of tooth |
| Dysbiosis of oral flora | Altered oral flora is known to be the causative agents of endodontic and periodontal infections. In addition, they also alter the regulation of inflammatory mechanisms of oral cancer |
| Masticatory efficiency | It is often compromised as a result of oncological surgery performed at the expense of functional anatomy. Often, the number of occluding posterior teeth is found to be reduced in the oral cancer patients associated with cachexia |
| Trismus | It is primarily seen as a complication of the treatment of oral cancer and affects the nutritional status of the patients |
| Xerostomia | It is the most important risk factor for carious lesions due to radiation therapy |
| Radiation caries | It is characterized by a brownish-black discoloration of the cervical, cuspal, and incisal region of the tooth structure |
| Osteoradionecrosis | It is also seen as a complication of radiation therapy which often involves the mandible |
Essential nutritional intake of cachexic patients according to the European Society of Parenteral and Enteral Nutrition guidelines[40]
| The current recommendation of nutritional intake | Description |
|---|---|
| Protein | Protein intake to prevent low muscle mass in cancer |
| 1.0-1.5 g/kg/day | |
| Branched-chain AA | These have a significant role in the promotion of protein synthesis and amelioration of muscle mass in cancer |
| Beta-HMB | It is a potential preventative supplement, known to reduce the degradation of protein thus modulating the protein turnover |
| Recommended supplementation: 3 g of HMB with 14 g of glutamine and arginine each | |
| Glutamine | Acts as a nutrient for metabolism of muscle protein |
| Acts as a source of energy for enterocytes in the gastrointestinal tract | |
| Recommended supplementation: 0.3 g/kg/day | |
| Carnitine | Known to enhance the work performing moiety of the body tissues |
| Lower levels are seen due to reduced food intake and increased excretion of urine in cachexic patients | |
| Creatine | Known to improve lean mass and function of muscle and improves intensity bouts of activity |
| Eicosapentaenoic acid and fish oil | Being an anti-inflammatory substance, it enhances the performance status by increasing weight gain |
| Recommended supplementation: 2.2 g/day | |
| Vitamins and minerals | Essential: A, B, C, D, E, selenium and zinc of which Vitamin A and E are depleted due to RT |
| Vitamin D improves muscle mass and function either with or without exercise | |
| Recommended Supplementation: 600-800 IU of Vitamin D combined with whey protein | |
| Intake of fluid | Normal fluid status maintains blood pressure and perfusion |
| Recommended supplementation: 3.7 L/day (males), 2.7 L/day (females) |
HMB: Hydroxy Beta-methyl butyrate, AA: Aminoacids, RT: Radiation therapy